Reproductive System - Level 2.2 Flashcards
Definition of breast fibroadenoma?
- Benign overgrowth of collagenous mesenchyme of one breast lobule
Epidemiology of breast fibroadenoma?
- Most common type of breast lesion in 20-30s
- Usually <30 but can occur up to menopause
Types of breast fibroadenoma?
o Common
o Giant - >5cm
o Juvenile – occurring in adolescent girls
Pathology of breast fibroadenoma?
- Thought to be increased sensitivity to oestrogen and HRT increases incidence
Symptoms of breast fibroadenoma?
- Firm, smooth lump o Mobile o Painless o Well-defined, rubbery - May be multiple - 1/3 regress, 1/3 stay same, 1/3 increase in size
Assessment of breast fibroadenoma?
Referral to specialist breast clinic – triple assessment
o Clinical examination
o US <40, mammography >40
o Needle biopsy (may or may not be required)
Management of breast fibroadenoma?
Observation and reassurance
o 25% get smaller or completely disappear
If large or woman over 40, surgical excision
If painful:
o Better-fitting bra during the day
o Soft support bra at night
o Oral PRN analgesia – paracetamol & ibuprofen
Types of breast cancer - malignant?
Infiltrating/invasive ductal carcinoma (70/80%)
Lobular Carcinoma (10%)
Medullary
Papillary
- Spreads to liver, lung and bones
Types of breast cancer - benign?
DCIS
LCIS
Types of breast cancer - other?
Paget’s
• Paget cell tumour with eczema-like rash, straw/blood-coloured discharge and burning sensation
Phylloides tumour
• Fast-growing, leaf-like architecture from periductal stromal cells
Epidemiology of breast cancer?
- Most common cancer in women
- 15% of all new cancer cases in females
- 1 in 8 women will develop breast cancer
Risk factors of breast cancer?
o Increased Age o Increased oestrogen exposure (late childbearing, nulliparity, early menarche, late menopause, obesity) o OCP and HRT o Obesity o Alcohol o Ionising Radiation o FHx o Genetics BRCA 1 & 2
Symptoms of benign breast cancer?
o Peripheral (younger women), central (older)
o Small, soft lump
o Discharge – blood/fluid
o May be painful
Symptoms of malignant breast cancer?
o Painless, increasing mass, firm, fixed, irregular o Nipple Discharge o Skin Tethering o Ulceration o Oedema/Erythema o P’eau d’orange o Axilla/Supraclavicular lymphadenopathy - Metastatic Disease o Malaise, fatigue, weight loss
Screening programme of breast cancer?
- Screening programme
o All women aged from 50 to 71st birthday invited every 3 years for mammogram
Assessment of breast cancer?
- Triple Assessment o Clinical assessment o Bilateral mammogram o Targeted USS and biopsy of area, axillae and sentinel nodes Core biopsy/FNA
Imaging of breast cancer?
o USS (if lump)
o CT Scan & Isotopic bone scan (if concerned about mets)
o PET CT (considering radical treatment)
Staging of breast cancer?
o TNM staging
o ER, PR, HER2 status on all invasive breast cancers
o BRCA 1 and 2 mutation testing if <50 with triple negative breast cancer
When to refer for 2 week appointment in suspected breast cancer?
- 2-week referral
o >30 with unexplained breast lump
o >50 with discharge, retraction, other changes of concern
Management of breast cancer - early or locally advanced disease?
Neoadjuvant chemotherapy Neoadjuvant endocrine therapy Surgery ‘standard’ Adjuvant Systemic Therapy Adjuvant Radiotherapy
Management of breast cancer - early or locally advanced disease - neoadjuvant chemotherapy?
- If ER-negative invasive breast cancer
- HER2-positive invasive breast cancer
- Triple-negative invasive breast cancer
Management of breast cancer - early or locally advanced disease - neoadjuvant endocrine therapy?
- Postmenopausal ER positive invasive breast cancer if no indication for chemotherapy
- Pertuzumab + trastuzumab and chemotherapy if HER2-positive breast cancer
Management of breast cancer - early or locally advanced disease - surgery?
• For localised disease – mastectomy or wide local excision with post-op radiotherapy
o Selection depends on location, size, single or multifocal disease
• Assessment of axillary lymph nodes/clearance
• If no metastases, sentinel node biopsy
o Inject tracer and can be removed
Management of breast cancer - early or locally advanced disease - adjuvant systemic therapy?
Chemotherapy
o Reduces mortality when used adjuvant, best in women less than 55
Her 2 Targeted
o Trastuzamab in HER-2-positive and given for 12 months
Endocrine
o Tamoxifen given for 5 years when tumours ER/PR positive
Increased risk of thrombosis and endometrial cancer, SE: mood changes, vaginal discharge and loss of libido
o Aromatase Inhibitors (Anastrazole)
Offered in post-menopausal women ER-positive
SE osteoporosis, mood changes, vaginal dryness, loss of libido
Bisphosphonates
o Postmenopausal women with node-positive invasive breast cancer